{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:47:41Z","timestamp":1773827261440,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Penn State Great Valley"},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-136\/2025-03\/200017"],"award-info":[{"award-number":["451-03-136\/2025-03\/200017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Feature selection approaches should satisfy all evaluation criteria required by state-of-the-art chemoinformatic models. Our aim is to develop a methodology that is robust, interpretable and computationally efficient. Methods: This study presents a robust methodology for developing highly interpretable and computationally efficient predictive models, with a specific application in the discovery of SARS-CoV-2 main protease inhibitors. We evaluated various descriptor selection procedures to identify a transparent and reproducible approach that provides actionable insights for data-driven decisions. The models were trained and tested using molecules from the CHEMBL database and further validated on an external set of compounds. Results: Our findings demonstrate that a recently proposed procedure, combining the FeatureWiz algorithm with stepwise feature selection, is the only approach that satisfies all evaluation criteria required by state-of-the-art chemoinformatic models. In particular, we found that models based on two-dimensional descriptors and Ordinary Least Squares regression achieved the best results. Conclusions: Our framework and the choices made offer significant advantages in a decision-making context due to their inherent interpretability and computational efficiency. Our derived models, benchmarked against those in the literature, serve as effective, transparent tools for the rapid and reliable prediction of biological activity, providing a validated framework for data-driven decisions in drug discovery and beyond.<\/jats:p>","DOI":"10.3390\/ph19030498","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:35:08Z","timestamp":1773819308000},"page":"498","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Data-Driven Approach for Interpretable and Efficient Predictive Modeling: A Case Study in SARS-CoV-2 Protease Inhibitor Discovery Through Feature Selection"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-9005","authenticated-orcid":false,"given":"Branislav","family":"Stankovi\u0107","sequence":"first","affiliation":[{"name":"Department for Nuclear and Plasma Physics, Vin\u010da Institute of Nuclear Sciences\u2014National Institute of the Republic of Serbia, University of Belgrade, P.O. Box 522, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-7487","authenticated-orcid":false,"given":"Sang-Yong","family":"Oh","sequence":"additional","affiliation":[{"name":"School of Professional Graduate Studies at Great Valley, The Pennsylvania State University, Malvern, PA 19355, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-1973","authenticated-orcid":false,"given":"Du\u0161an","family":"Ramljak","sequence":"additional","affiliation":[{"name":"School of Professional Graduate Studies at Great Valley, The Pennsylvania State University, Malvern, PA 19355, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, December 02). COVID-19 Dashboard. Available online: https:\/\/data.who.int\/dashboards\/covid19."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11030-020-10134-x","article-title":"Therapeutics for COVID-19: From computation to practices\u2014Where we are, where we are heading to","volume":"25","author":"Ojha","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"173890","DOI":"10.1016\/j.ejphar.2021.173890","article-title":"A review of potential suggested drugs for coronavirus disease (COVID-19) treatment","volume":"895","author":"Tarighi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1042\/BCJ20210199","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease","volume":"478","author":"Canal","year":"2021","journal-title":"Biochem. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/1062936X.2020.1776388","article-title":"Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases","volume":"31","author":"Kumar","year":"2020","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/1386207323666200914094712","article-title":"In Silico Modeling of Small Molecule Carboxamides as Inhibitors of SARS-CoV 3CL Protease: An Approach Towards Combating COVID-19","volume":"24","author":"Khan","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"132041","DOI":"10.1016\/j.molstruc.2021.132041","article-title":"Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences","volume":"1251","author":"Adhikari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104483","DOI":"10.1016\/j.compbiomed.2021.104483","article-title":"QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors","volume":"134","author":"Ishola","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/07391102.2020.1821779","article-title":"In Silico Modeling for Quick Prediction of Inhibitory Activity Against 3CLpro Enzyme in SARS CoV Diseases","volume":"40","author":"De","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s13738-021-02426-2","article-title":"High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors","volume":"19","author":"Sepehri","year":"2022","journal-title":"J. Iran. Chem. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2200198","DOI":"10.1002\/minf.202200198","article-title":"Discovery of natural-derived Mpro inhibitors as therapeutic candidates for COVID-19: Structure-based pharmacophore screening combined with QSAR analysis","volume":"42","author":"Khanfar","year":"2023","journal-title":"Mol. Inform."},{"key":"ref_13","first-page":"1372","article-title":"2D QSAR Approach to Develop Newer Generation Small Molecules Active Against SARS-COVID","volume":"14","author":"Saha","year":"2023","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11512","DOI":"10.1039\/D1NJ02127C","article-title":"A computational approach for designing novel SARS-CoV-2 Mpro inhibitors: Combined QSAR, molecular docking, and molecular dynamics simulation techniques","volume":"45","author":"Tong","year":"2021","journal-title":"New J. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Song, F., Sun, H., Ma, X., Wang, W., Luan, M., Zhai, H., Su, G., and Liu, Y. (2023). QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1185004"},{"key":"ref_16","first-page":"326","article-title":"Discovery of new inhibitors of Sars-CoV: QSAR study using Density functional theory (DFT) and statistical methods","volume":"14","author":"Ousaa","year":"2023","journal-title":"J. Mater. Environ. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.chemosphere.2014.03.067","article-title":"Theoretical study of the molecular properties of dimethylanthracenes as properties for the prediction of their biodegradation and mutagenicity","volume":"111","author":"Ostojic","year":"2014","journal-title":"Chemosphere"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhazmat.2016.07.035","article-title":"Theoretical study of nitrodibenzofurans: A possible relationship between molecular properties and mutagenic activity","volume":"318","author":"Stankovic","year":"2016","journal-title":"J. Hazard. Mater."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24891","DOI":"10.1021\/acsomega.1c03736","article-title":"Theoretical Studies on the Molecular Properties, Toxicity, and Biological Efficacy of 21 New Chemical Entities","volume":"6","author":"Srivastava","year":"2021","journal-title":"ACS Omega"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1557\/s43580-023-00590-6","article-title":"Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19","volume":"8","author":"Morad","year":"2023","journal-title":"MRS Adv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"54603","DOI":"10.1007\/s11356-024-34800-x","article-title":"A novel procedure for selection of molecular descriptors: QSAR model for mutagenicity of nitroaromatic compounds","volume":"31","author":"Stankovic","year":"2024","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/C7SC02664A","article-title":"MoleculeNet: A benchmark for molecular machine learning","volume":"9","author":"Wu","year":"2018","journal-title":"Chem. Sci."},{"key":"ref_23","first-page":"61","article-title":"Principles of QSAR Modeling: Comments and Suggestions From Personal Experience","volume":"5","author":"Gramatica","year":"2020","journal-title":"Int. J. Quant. Struct.-Prop. Relatsh."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acs.jcim.8b00825","article-title":"Interpretation of QSAR Models by Coloring Atoms According to Changes in Predicted Activity: How Robust Is It?","volume":"59","author":"Sheridan","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Visan, A.I., and Negut, I. (2024). Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery. Life, 14.","DOI":"10.3390\/life14020233"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.appet.2016.04.025","article-title":"Proximity of snacks to beverages increases food consumption in the workplace: A field study","volume":"103","author":"Baskin","year":"2016","journal-title":"Appetite"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1039\/D0CS00098A","article-title":"QSAR without borders","volume":"49","author":"Muratov","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"ref_28","unstructured":"Guyon, I., Luxburg, U.V., Bengio, S., Wallach, H., Fergus, R., Vishwanathan, S., and Garnett, R. (2017). A Unified Approach to Interpreting Model Predictions. Proceedings of the Advances in Neural Information Processing Systems, Curran Associates, Inc."},{"key":"ref_29","unstructured":"Organisation for Economic Co-Operation and Development (OECD) (2014). Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models, OECD. ENV\/JM\/MONO(2007)2\/REV1."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s42269-020-00333-9","article-title":"In silico studies of 2,5-disubstituted furans as active antimalarial drug candidates","volume":"44","author":"Mahmud","year":"2020","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104734","DOI":"10.1016\/j.chemolab.2022.104734","article-title":"Multi-target QSAR modeling for the identification of novel inhibitors against Alzheimer\u2019s disease","volume":"233","author":"Kumar","year":"2023","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Espinoza, G.Z., Angelo, R.M., Oliveira, P.R., and Honorio, K.M. (2021). Evaluating Deep Learning models for predicting ALK-5 inhibition. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246126"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103888","DOI":"10.1016\/j.chemolab.2019.103888","article-title":"Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods","volume":"196","author":"Tian","year":"2020","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: A molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J. Cheminform."},{"key":"ref_37","first-page":"45","article-title":"Applicability Domain for QSAR Models: Where Theory Meets Reality","volume":"1","author":"Gadaleta","year":"2016","journal-title":"Int. J. Quant. Struct.-Prop. Relatsh."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/acs.jcim.6b00088","article-title":"A Historical Excursus on the Statistical Validation Parameters for QSAR Models: A Clarification Concerning Metrics and Terminology","volume":"56","author":"Gramatica","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1021\/ci300084j","article-title":"Real External Predictivity of QSAR Models. Part 2. New Intercomparable Thresholds for Different Validation Criteria and the Need for Scatter Plot Inspection","volume":"52","author":"Chirico","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.aca.2003.12.010","article-title":"Detecting \u201cbad\u201d regression models: Multicriteria fitness functions in regression analysis","volume":"515","author":"Todeschini","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1747-0285.2008.00629.x","article-title":"Mutagenicity of Nitrated Polycyclic Aromatic Hydrocarbons: A QSAR Investigation","volume":"71","author":"Singh","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_42","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2025, December 02). Gaussian 16 Revision C.01. Available online: https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=3834728."},{"key":"ref_43","unstructured":"Seshadri, R. (2025, December 02). Featurewiz. Available online: https:\/\/github.com\/AutoViML\/featurewiz."},{"key":"ref_44","unstructured":"Calzolari, M. (2025, December 02). Manuel-Calzolari\/Sklearn-Genetic: Sklearn-Genetic 0.6.0. Available online: https:\/\/zenodo.org\/records\/10539898."},{"key":"ref_45","unstructured":"Landrum, G. (2025, December 02). RDKit: Open-Source Cheminformatics Software. Available online: https:\/\/github.com\/rdkit\/rdkit."},{"key":"ref_46","unstructured":"(2025, December 02). Open Babel Development Team. Open Babel. Available online: http:\/\/openbabel.org\/docs\/index.html."},{"key":"ref_47","unstructured":"Chemaxon (MarvinSketch, 2024). MarvinSketch, [24.3.2]."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/3\/498\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:42:15Z","timestamp":1773819735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/3\/498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ph19030498"],"URL":"https:\/\/doi.org\/10.3390\/ph19030498","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}